PMC:7319919 / 3691-3902 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T28","span":{"begin":110,"end":118},"obj":"Chemical"}],"attributes":[{"id":"A28","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_45783"}],"text":"of pulmonary opacities was confirmed. Moreover, improvement in laboratory parameters was observed on day 5 of imatinib so it was stopped and the patient was subsequently discharged on day 16 of symptoms after al"}

{"project":"LitCovid-PubTator","denotations":[{"id":"96","span":{"begin":145,"end":152},"obj":"Species"},{"id":"104","span":{"begin":110,"end":118},"obj":"Chemical"}],"attributes":[{"id":"A96","pred":"tao:has_database_id","subj":"96","obj":"Tax:9606"},{"id":"A104","pred":"tao:has_database_id","subj":"104","obj":"MESH:D000068877"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"of pulmonary opacities was confirmed. Moreover, improvement in laboratory parameters was observed on day 5 of imatinib so it was stopped and the patient was subsequently discharged on day 16 of symptoms after al"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T14","span":{"begin":3,"end":22},"obj":"Phenotype"}],"attributes":[{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0031457"}],"text":"of pulmonary opacities was confirmed. Moreover, improvement in laboratory parameters was observed on day 5 of imatinib so it was stopped and the patient was subsequently discharged on day 16 of symptoms after al"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T43","span":{"begin":3,"end":12},"obj":"UBERON:0002048"},{"id":"T44","span":{"begin":110,"end":118},"obj":"CHEBI:45783;CHEBI:45783"},{"id":"T74081","span":{"begin":3,"end":12},"obj":"UBERON:0002048"},{"id":"T62264","span":{"begin":110,"end":118},"obj":"CHEBI:45783;CHEBI:45783"}],"text":"of pulmonary opacities was confirmed. Moreover, improvement in laboratory parameters was observed on day 5 of imatinib so it was stopped and the patient was subsequently discharged on day 16 of symptoms after al"}